Growth Metrics

Armata Pharmaceuticals (ARMP) Free Cash Flow (2016 - 2026)

Quarterly results put Free Cash Flow at -$5.8 million for Q1 2026, up 23.88% from a year ago — trailing twelve months through Mar 2026 was -$24.5 million (up 32.54% YoY), and the annual figure for FY2025 was -$26.3 million, up 33.29%.

Armata Pharmaceuticals has reported Free Cash Flow over the past 14 years, most recently at -$5.8 million for Q1 2026.

  • Free Cash Flow reached -$5.8 million in Q1 2026 per ARMP's latest filing, up from -$6.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$3.8 million in Q1 2022 and bottomed at -$19.6 million in Q1 2023.
  • Median Free Cash Flow over the past 5 years was -$9.3 million (2022), compared with a mean of -$9.5 million.
  • The largest annual shift saw Free Cash Flow tumbled 421.99% in 2023 before it skyrocketed 50.67% in 2025.
  • Over 5 years, Free Cash Flow stood at -$10.0 million in 2022, then decreased by 4.75% to -$10.5 million in 2023, then rose by 25.28% to -$7.8 million in 2024, then grew by 14.32% to -$6.7 million in 2025, then grew by 13.1% to -$5.8 million in 2026.
  • Business Quant data shows Free Cash Flow for ARMP at -$5.8 million in Q1 2026, -$6.7 million in Q4 2025, and -$4.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.29 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 848.30 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 48.67 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -5.85 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.85 Mn
Mar 31, 2026 -5.85 Mn
Dec 31, 2025 -6.73 Mn
Dec 31, 2025 -6.73 Mn
Sep 30, 2025 -4.54 Mn
Sep 30, 2025 -4.54 Mn
Jun 30, 2025 -7.36 Mn
Jun 30, 2025 -7.36 Mn
Mar 31, 2025 -7.68 Mn
Mar 31, 2025 -7.68 Mn
Dec 31, 2024 -7.85 Mn
Dec 31, 2024 -7.85 Mn
Sep 30, 2024 -9.20 Mn
Sep 30, 2024 -9.20 Mn
Jun 30, 2024 -11.54 Mn
Jun 30, 2024 -11.54 Mn
Mar 31, 2024 -10.83 Mn
Mar 31, 2024 -10.83 Mn
Dec 31, 2023 -10.51 Mn
Dec 31, 2023 -10.51 Mn
Sep 30, 2023 -13.20 Mn
Sep 30, 2023 -13.20 Mn
Jun 30, 2023 -12.28 Mn
Jun 30, 2023 -12.28 Mn
Mar 31, 2023 -19.58 Mn
Mar 31, 2023 -19.58 Mn
Dec 31, 2022 -10.03 Mn
Dec 31, 2022 -10.03 Mn
Sep 30, 2022 -11.63 Mn
Sep 30, 2022 -11.63 Mn
Jun 30, 2022 -9.28 Mn
Jun 30, 2022 -9.28 Mn
Mar 31, 2022 -3.75 Mn
Mar 31, 2022 -3.75 Mn
Dec 31, 2021 -8.83 Mn
Dec 31, 2021 -8.83 Mn
Sep 30, 2021 -5.55 Mn
Sep 30, 2021 -5.55 Mn
Jun 30, 2021 -4.73 Mn
Jun 30, 2021 -4.73 Mn
Mar 31, 2021 -5.77 Mn
Mar 31, 2021 -5.77 Mn
Dec 31, 2020 -6.67 Mn
Dec 31, 2020 -6.67 Mn
Sep 30, 2020 -3.96 Mn
Sep 30, 2020 -3.96 Mn
Jun 30, 2020 -4.13 Mn
Jun 30, 2020 -4.13 Mn
Mar 31, 2020 -4.34 Mn
Mar 31, 2020 -4.34 Mn
Dec 31, 2019 -2.75 Mn
Dec 31, 2019 -2.75 Mn
Sep 30, 2019 -4.50 Mn
Sep 30, 2019 -4.50 Mn
Jun 30, 2019 -5.95 Mn
Jun 30, 2019 -5.95 Mn
Mar 31, 2019 -2.60 Mn
Mar 31, 2019 -2.60 Mn
Dec 31, 2018 -3.59 Mn
Dec 31, 2018 -3.59 Mn
Sep 30, 2018 -2.18 Mn
Sep 30, 2018 -2.18 Mn
Jun 30, 2018 -1.88 Mn
Jun 30, 2018 -1.88 Mn
Mar 31, 2018 -3.54 Mn
Mar 31, 2018 -3.54 Mn
Dec 31, 2017 -2.39 Mn
Dec 31, 2017 -2.39 Mn
Sep 30, 2017 -626,000.00
Sep 30, 2017 -626,000.00
Jun 30, 2017 -2.93 Mn
Jun 30, 2017 -2.93 Mn
Mar 31, 2017 -3.30 Mn
Mar 31, 2017 -3.30 Mn
Dec 31, 2016 -1.51 Mn
Dec 31, 2016 -1.51 Mn
Sep 30, 2016 -3.16 Mn
Sep 30, 2016 -3.16 Mn
Jun 30, 2016 -3.02 Mn
Jun 30, 2016 -3.02 Mn